Critical issues in chronic prostatitis

Archivio Italiano di Urologia e Andrologia

Volumn 82, Issue 2, 2010, Pages 75-82

  Magri, Vittorio ^a   Perletti, Gianpaolo ^b   Bartoletti, Riccardo ^c   Cai, Tommaso ^c   Emelyanova, Irina ^d   Mehik, Aare ^e   Morgia, Giuseppe ^f   Skerk, Visnja ^g   Trinchieri, Alberto ^h   Wagenlehner, Florian M E ⁱ   Naber, Kurt G ^j  

^a PARKINSON INSTITUTE   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Medical Center Rus   (Russian Federation)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF MESSINA   (Italy)

^g Croatia   (Croatia)

^h A MANZONI HOSPITAL   (Italy)

ⁱ JUSTUS LIEBIG UNIVERSITY   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Chronic bacterial prostatitis; Chronic pelvic pain syndrome; NIH CPSI; P CPPS; Prostatitis

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GRASS POLLEN EXTRACT; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PLACEBO; PRULIFLOXACIN; PYGEUM AFRICANUM EXTRACT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SABAL EXTRACT; SULBUTIAMINE; TAMSULOSIN; THIOCTIC ACID; TRIMETHOPRIM; UNINDEXED DRUG; UREIDOPENICILLIN DERIVATIVE;

ABDOMINAL RADIOGRAPHY; ACUTE BACTERIAL PROSTATITIS; ASYMPTOMATIC INFLAMMATORY PROSTATITIS; BACTERIUM CULTURE; BLADDER DYSFUNCTION; CHRONIC BACTERIAL PROSTATITIS; CHRONIC PROSTATITIS; CLINICAL TRIAL; CYSTOSCOPY; DIAGNOSTIC PROCEDURE; DIGITAL RECTAL EXAMINATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EUROPE; HERBAL MEDICINE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE SEXUAL DYSFUNCTION; MEDICAL RESEARCH; PELVIS PAIN SYNDROME; PROSTATE BIOPSY; PROSTATITIS; QUESTIONNAIRE; RESEARCH PRIORITY; REVIEW; SEMEN ANALYSIS; SEXUAL DYSFUNCTION; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT INFECTION; CLASSIFICATION; MALE;

BIOMEDICAL RESEARCH; HUMANS; MALE; PROSTATITIS;

EID: 77955797434     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Schaeffer AJ. Clinical practice - Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006; 355:1690-698.
2. Nickel JC, Moon T. Chronic bacterial prostatitis: an evolving clinical enigma. Urology 2005; 66:2-8. (Pubitemid 41002174)
3. Murphy AB, Macejko A, Taylor A, Nadler RB. Chronic prostatitis: management strategies. Drugs 2009; 69:71-84.
4. Wagenlehner FM, Diemer T, Naber KG, et al. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status. Andrologia 2008; 40:100-04.
5. Wagenlehner FM, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect 2006; 12:S67-S80.
6. Weidner W, Wagenlehner FM, Marconi M, et al. Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications. Andrologia 2008; 40:105-11.
7. Nickel JC, Alexander RB, Anderson R, et al. Chronic Prostatitis Collaborative Research Network Study Groups: Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Urol Rep 2008; 9:320-27.
8. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282:236-37.
9. Nickel JC. Alpha blockers for the treatment of prostatitis-like syndromes. Rev Urol 2006; 8:S26-S34.
10. Shoskes DA, Nickel JC, Dolinga R, et al. Clinical Phenotyping of Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Correlation With Symptom Severity. Urology 2009; 73:538-42.
11. Shoskes DA, Nickel JC, Rackley RR, et al. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer and Prostatic Dis 2008; 12:177-83.
12. Schaeffer AJ, Knauss JS, Landis JR, et al. Chronic Prostatitis Collaborative Research Network Study Group. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168:1048-53.
13. Krieger JN, Ross SO, Limaye AP, et al. Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis. Urology 2005; 66:721-25.
14. Skerk V, Markovinovic L, Zekan S, et al. The significance of Chlamydia trachomatis in urethritis and prostatitis - differences in therapeutic approach - Croatian experience. J Chemother 2009; 21:63-7.
15. Skerk V, Krhen I, Schonwald S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004; 24:S53-S56. (Pubitemid 39208862)
16. Skerk V, Sternak SL, Rogliç S, et al. Diagnosis and treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2005; 17:570-71. (Pubitemid 41695609)
17. Mazzoli S, Cai T, Rupealta V, et al. Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur Urol 2007; 51:1385-93. (Pubitemid 46436296)
18. Motrich RD, Cuffini C, Oberti JP, et al. Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients. J Infect 2006; 53:175-83. (Pubitemid 44249619)
19. Naber KG, Roscher K, Botto H, Schaefer V. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 2008; 32:145-53.
20. Magri V, Trinchieri A, Pozzi G, Ret al. Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis. Int J Antimicrob Agents 2007; 29:549-56.
21. Nickel JC, Xiang J. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 2008; 179:1391-5.
22. Magri V, Trinchieri A, Ceriani I, et al. Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome. Arch Ital Urol Androl 2007; 79:93-8.
23. Dellabella M, Milanese G, Muzzonigro G. Correlation between ultrasound alterations of the preprostatic sphincter and symptoms in patients with chronic prostatitis-chronic pelvic pain syndrome. J Urol 2006; 176:112-8. (Pubitemid 43833175)
24. Magri V, Wagenlehner FM, Montanari E, et al. Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. Asian J Androl 2009; 11:461-77.
25. Loran OB, Segal AS. A system of comprehensive assessment of symptoms in chronic prostatitis (CAS-XII). Urologiia 2001; 5:16-9.
26. Lee SW, Liong ML, Yuen KH, et al. Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology 2008; 71:79-84
27. Mehik A, Hellstrom P, Sarpola A, et al. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001; 88:35-8.
28. Muller A, Mulhall JP. Sexual dysfunction in the patient with prostatitis. Curr Urol Rep 2006; 7:307-12. (Pubitemid 44623993)
29. Sadeghi-Nejad H, Seftel A. Sexual dysfunction and prostatitis. Curr Urol Rep 2006; 7:479-84.
30. Smith KB, Tripp D, Pukall C, et al. Predictors of sexual and relationship functioning in couples with Chronic Prostatitis/Chronic Pelvic Pain Syndrome. J Sex Med 2007; 4:734-44. (Pubitemid 46779310)
31. Trinchieri A, Magri V, Cariani L, et al. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl 2007; 79:67-70.
32. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998; 159:883-7. (Pubitemid 28106550)
33. Geppetti P, Nassini R, Materazzi S, et al. The concept of neurogenic inflammation. BJU Int 2008; 101:S2-S6.
34. Trevisani M, Campi B, Gatti R, et al. The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract. Eur Urol 2007; 52:901-8.
35. Mehik A, Alas P, Nickel JC, et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003; 62:425-9.
36. Cheah PY, Liong ML, Yuen KH, et al. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology 2004; 64:881-6.
37. Nickel JC, Elhilali M, Emberton M, et al. The Alf-One Study Group. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int 2006; 97:1242-6.
38. Alexander RB, Propert KJ, Schaeffer AJ, et al. Chronic Prostatitis Collaborative Research Network: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004; 141:581-9.
39. Nickel JC, Krieger JN, McNaughton-Collins M, et al. Chronic Prostatitis Collaborative Research Network: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 2008; 359:2663-73.
40. Nickel JC, Mullins C, Tripp DA. Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome. World J Urol 2008; 26:167-72.